EP Patent

EP2596393A1 — Bend-resistant single-mode optical fibre

Assigned to Prysmian SpA · Expires 2013-05-29 · 13y expired

What this patent protects

The present invention relates to a single-mode optical fibre for transmitting optical signals comprising: a central core region for guiding the optical signals, and a cladding region surrounding the core region and comprising a void-containing annular layer containing randomly di…

USPTO Abstract

The present invention relates to a single-mode optical fibre for transmitting optical signals comprising: a central core region for guiding the optical signals, and a cladding region surrounding the core region and comprising a void-containing annular layer containing randomly distributed voids, wherein the void-containing layer is doped with fluorine at a concentration of less than 1 wt% and has a radial thickness equal to or smaller than 3 μm.

Drugs covered by this patent

Patent Metadata

Patent number
EP2596393A1
Jurisdiction
EP
Classification
—
Expires
2013-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Prysmian SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.